The Patent Finder

Jennerex, Inc.

Also on record
Records under this name other than patents Jennerex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Jennerex, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,180,149Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,180,151Oncolytic vaccinia virus combination cancer therapy
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,719,105Methods and compositions for production of vaccinia virus
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 8,980,246Oncolytic Vaccinia Virus Cancer Therapy
Term ended
Term ended Sep 7, 2026 · Medium confidence
Term endedTerm ended Sep 7, 2026Medium confidence
US 9,226,977Oncolytic vaccinia virus cancer therapy
Formerly held
Term ended
Ended no later than Sep 7, 2026 · USPTO record
Term endedEnded no later than Sep 7, 2026USPTO record
US 8,747,837Oncolytic vaccinia virus combination cancer therapy
Formerly held
Lapsed on the fee record
Ended Jun 10, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 10, 2026USPTO record
US 9,919,047Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
Formerly held
Lapsed on the fee record
Ended Mar 20, 2026 · USPTO record
Lapsed on the fee recordEnded Mar 20, 2026USPTO record
US 8,986,674Methods and Compositions Concerning Poxviruses and Cancer
Formerly held
Term ended
Term ended Dec 16, 2023 · Medium confidence
Term endedTerm ended Dec 16, 2023Medium confidence
US 8,329,164Methods and compositions concerning poxviruses and cancer
Formerly held
Term ended
Term ended Aug 11, 2023 · USPTO record
Term endedTerm ended Aug 11, 2023USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited